Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

https://oncologypro.esmo.org/Meeting-Resour...lar-profiling-of-angiosarcomas-of-the-breast

Sarcoma ... Soft Tissue Sarcomas 0 Here below, you will find a list of all the latest content published on this website on the topic of Soft Tissue Sarcomas. The content is published in chronological order

Date: 27 Sep 2014
Presenter: Edibaldo Silva
Resources: Abstract
Topics: Soft Tissue Sarcomas, Pathology/Molecular Biology, Basic Scientific Principles

https://oncologypro.esmo.org/Meeting-Resour...discussant-abstracts-1422PD-1423PD-and-LBA46

View the abstracts discussed: Phase 2 trial to evaluate the efficacy and safety of dovitinib in patients (pts) with gastrointestinal stromal tumor (GIST) refractory and/or intolerant ... Sarcoma ... Sarcoma 0 Here below, you will find a list of all the latest content published on this website on the topic of Sarcoma. The content is published in chronological order. Find out more about our

Date: 27 Sep 2014
Presenter: Nicolas Penel
Resources: Presentation, Webcast
Topic: Sarcoma

https://oncologypro.esmo.org/Meeting-Resour...-refractory-and-or-intolerant-to-imatinib-IM

-10153 - Torino/IT, §4§Sarcoma And Melanoma Units, Son Espases Hospital, Palma de Mallorca/ES, §5§Adult Mesenchymal Tumour Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan ...

Aim

Sunitinib is approved for advanced GIST resistant/refractory to IM; however, disease control rate (DCR) at 12 wk was only ≈ 40%. Thus, novel therapeutic second-line strategies ... Phase 2 trial to evaluate the efficacy and safety of dovitinib in patients (pts) with gastrointestinal stromal tumor (GIST) refractory and/or intolerant to imatinib (IM) ... Sarcoma ... in chronological order. Find out more about our content categorisation . None 0 0 0 1 1470002400 GIST 0 Here below, you will find a list of all the latest content published on this website on the topic of GIST

Date: 27 Sep 2014
Presenter: Heikki Joensuu
Resources: Abstract
Topics: Anticancer Agents, GIST, Therapy, Biological Therapy

https://oncologypro.esmo.org/Meeting-Resour...ticenter-two-stage-phase-II-trial-SAKK-56-07

§1§Oncology, University Hospital Lausanne CHUV, 1011 - Lausanne/CH, §2§Sarcoma Unit, Institut de cancerologie Gustave Roussy, 94805 - Villejuif/FR, §3§Dept Of Medecine - Sarcoma Division, Institut ...

Aim

Tyrosine kinase inhibitors (TKIs) have improved the outcome of patients (pts) with gastrointestinal stromal tumor (GIST), but most patients eventually develop resistance and progress ... Sarcoma ... in chronological order. Find out more about our content categorisation . None 0 0 0 1 1470002400 GIST 0 Here below, you will find a list of all the latest content published on this website on the topic of GIST

Date: 27 Sep 2014
Presenter: Michael Montemurro
Resources: Abstract
Topics: Anticancer Agents, GIST, Therapy, Biological Therapy

https://oncologypro.esmo.org/Meeting-Resour...panish-Group-for-Sarcoma-Research-GEIS-study

Aim

Relevant prognostic factors for relapse free survival (RFS) in GIST relies on clinical and pathologic variables as size, mitoses, location or tumor rupture. However, being GIST a solid ... Integrating genotype in risk classification for GIST recurrence. A Spanish Group for Sarcoma Research (GEIS) study ... Sarcoma ... GIST 0 Here below, you will find a list of all the latest content published on this website on the topic of GIST. The content is published in chronological order. Find out more about our content

Date: 27 Sep 2014
Presenter: Javier Martin Broto
Resources: Abstract
Topics: GIST, Pathology/Molecular Biology, Translational Research, Basic Scientific Principles, Basic Principles in the Management and Treatment (of cancer)

https://oncologypro.esmo.org/Meeting-Resour...e-kinase-inhibitor-TKI-therapy-early-results

§Ludwig Center At Dana-farber/harvard Cancer Center And Sarcoma Center, Dana-Farber Cancer Institute, 02215 - Boston/US, §4§Pathology, Brigham and Women's Hospital, 02115 - Boston/US, §5§Biostatistics ... KIT exon 11) and secondary (including KIT exon 17) resistance mutants. This in vitro activity suggests it may be effective in GIST pts with failure of prior TKI therapies.

Methods

GIST) after failure of tyrosine kinase inhibitor (TKI) therapy: early results ... Sarcoma ... in chronological order. Find out more about our content categorisation . None 0 0 0 1 1470002400 GIST 0 Here below, you will find a list of all the latest content published on this website on the topic of GIST

Date: 27 Sep 2014
Presenter: Michael Heinrich
Resources: Abstract
Topics: Anticancer Agents, GIST, Therapy, Biological Therapy

https://oncologypro.esmo.org/Meeting-Resour...iscussant-abstracts-1416PD-1417PD-and-1418PD

for GIST recurrence. A Spanish Group for Sarcoma Research (GEIS) study ... Sarcoma ... GIST 0 Here below, you will find a list of all the latest content published on this website on the topic of GIST. The content is published in chronological order. Find out more about our content

Date: 27 Sep 2014
Presenter: Axel Le Cesne
Resources: Presentation, Webcast
Topic: GIST

https://oncologypro.esmo.org/Meeting-Resour...munity-setting-An-Italian-survey-on-1238-pts

with TT from mid 2007 to December 2012 in 35 Italian Institutions.

Results

Median age was 66 yrs (range 24-91). Histology was clear cell (CC) (84%), with sarcomatoid component (7%), others (9

Date: 27 Sep 2014
Presenter: Felice Pasini
Resources: Abstract
Topics: Anticancer Agents, Renal Cell Cancer, Therapy, Biological Therapy

https://oncologypro.esmo.org/Meeting-Resour...and-cyclin-D-CDK4-6-pathway-activated-tumors

of Central Nervous System Malignancies. The content is published in chronological order. Find out more about our content categorisation . None 0 0 0 0 1167606000 Sarcoma 0 Here below, you will find a list

Date: 27 Sep 2014
Presenter: Birgit Geoerger
Resources: Abstract
Topics: Clinical Research, Central Nervous System Malignancies, Sarcoma, Translational Research, Basic Scientific Principles, Basic Principles in the Management and Treatment (of cancer)

https://oncologypro.esmo.org/Meeting-Resour...-transitional-carcinoma-of-the-urinary-tract

,4%), 2 renal cancers (4,4%), 2 Hepatocellular carcinomas (4,2%), 2 haematological tumours (4,4%), and 1 case of each of the following tumours: GIST, prostate, parotid, biliary track, glottis, thyroid

Date: 27 Sep 2014
Presenter: Andrea Vethencourt
Resources: Abstract
Topics: Urothelial Cancers, Aetiology, Epidemiology, Screening and Prevention, Basic Scientific Principles